Internal Medicine, Nephrology · Opelousas, LA
NPI
1477507531
Since 2006
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
3
Medicare group memberships
Hospitals
5
Hospital affiliations
927 E Prudhomme St
Opelousas, LA, 70570
Phone (337) 594-8381
Groups this clinician bills Medicare through
Medicare paid, 2024
$200K
2,410 services
Medicare patients, 2024
595
Average age 75
Drug cost, 2024
$1.8M
9,397 prescriptions
Company payments, 2025
$1,775
From 19 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Raphael J Higginbotham was code 99214 (office e&m - established), 611 times for 374 patients. In total Raphael J Higginbotham billed 2,410 services in 30 codes, and Medicare paid $200K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-07-13.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 611 | 374 | $74.89 | $46K |
| 99232 Hospital E&M - Subsequent | Facility | 517 | 134 | $50.20 | $26K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 452 | 267 | $10.55 | $4,770 |
| 90961 ESRD Related Services (not dialysis) | Office | 205 | 60 | $202.42 | $41K |
| 90960 ESRD Related Services (not dialysis) | Office | 178 | 57 | $239.96 | $43K |
| 99222 Hospital E&M - Initial | Facility | 117 | 98 | $83.57 | $9,778 |
| 99204 Office E&M - New | Office | 72 | 72 | $89.66 | $6,455 |
| 90966 ESRD Related Services (not dialysis) | Office | 66 | 12 | $193.70 | $13K |
| 90962 ESRD Related Services (not dialysis) | Office | 51 | 28 | $139.49 | $7,114 |
By year: 2022 $261K for 2,787 services; 2023 $242K for 2,147 services; 2024 $200K for 2,410 services.
Lab tests billed to Medicare, 2022
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 87811 Immunoassay | 39 | 39 | $41.15 | $1,605 |
Medicare prescription drug claims, 2024
In 2024, the drug Raphael J Higginbotham prescribed most often to Medicare patients was Calcitriol, with 527 prescriptions and refills. In total Raphael J Higginbotham wrote 9,397 Medicare prescriptions that cost $1.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Calcitriol Generic | 527 | 1,122 | 131 | $8,578 |
| Torsemide Generic | 501 | 956 | 135 | $7,720 |
| Amlodipine Besylate Generic | 483 | 1,031 | 134 | $2,500 |
| Carvedilol Generic | 355 | 741 | 86 | $2,080 |
| Farxiga Dapagliflozin Propanediol | 328 | 528 | 68 | $277K |
| Valsartan Generic | 279 | 507 | 72 | $5,800 |
| Furosemide Generic | 278 | 549 | 93 | $1,220 |
| Atorvastatin Calcium Generic | 238 | 599 | 65 | $2,853 |
| Losartan Potassium Generic | 228 | 508 | 65 | $2,031 |
| Nifedipine Er Nifedipine | 211 | 380 | 45 | $4,634 |
| Tamsulosin Hcl Generic | 198 | 343 | 44 | $2,300 |
| Rosuvastatin Calcium Generic | 183 | 362 | 44 | $2,842 |
| Pantoprazole Sodium Generic | 179 | 298 | 53 | $1,722 |
| Potassium Chloride Generic | 177 | 297 | 41 | $1,952 |
| Allopurinol Generic | 168 | 418 | 48 | $1,454 |
Brand drugs: 1,540 claims; generic drugs: 7,827 claims; opioid claims: 100.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Raphael J Higginbotham $1,775 ($1,775 in general payments such as food, travel and fees) from 19 companies. The largest payer was Mallinckrodt Hospital Products Inc. with $358.
| Company | Payments | Amount |
|---|---|---|
| Mallinckrodt Hospital Products Inc. | 10 | $358 |
| Novo Nordisk Inc NVO | 11 | $312 |
| Amgen Inc. AMGN | 6 | $179 |
| Calliditas Therapeutics US Inc. | 5 | $142 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $112 |
| Akebia Therapeutics Inc AKBA | 4 | $99.75 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 5 | $93.59 |
| Fresenius USA Marketing, Inc. | 4 | $84.91 |
| Ascendis Pharma Endocrinology Inc ASND | 4 | $69.84 |
| Novartis Pharmaceuticals Corporation NVS | 3 | $56.33 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.